p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors

National Medical Journal of India

Volumn 13, Issue 4, 2000, Pages 190-192

  Malhotra, Rajesh ^a,b   Morgan, D A F ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Queensland Bone Bank ^*  (Australia)

^c Queensland Bone Bank   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ALLOTRANSPLANTATION; ARTICLE; BLOOD; BONE TRANSPLANTATION; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR;

BONE TRANSPLANTATION; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HIV-2; HTLV-I ANTIBODIES; HUMANS; MALE; POLYMERASE CHAIN REACTION; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034220090     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Centers for Disease Control. Transmission of HIV through bone transplantation: Case report and public health recommendation. MMWR 1988;37:597-9.
2. Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TRR, Bottenfield S, Conley LJ, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992;326:726-32.
3. Morgan DAF, Ferguson KL, Benfield JEC, Johnstone PO. Bone banking in the 1990s - A safe efficient system. Curr Ortho 1993;7:36-43.
4. Buck BE, Malinim TI, Brown MD. Bone transplantation and human immunodeficiency virus. Clin Orth Rel Res 1989;240:129-36.
5. Gaines H, Albert J, von Sydow M, Sonnerborg A, Chiodi F, Ehmst A, et al. HIV antigenemia and virus isolation from plasma during primary HIV infection. Lancet 1987;1:1317-18.
6. Asselmeier MA, Caspari RB, Bottenfield S. A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sports Med 1993;21:170-5.
7. Lafeuillade A, Poggi C, Tamalet C, Profizi N. Relationship between immune complex-dissociated p24 antigen and human immunodeficiency virus type 1 RNA titers in plasma [letter comment on J Infect Dis 1995;172:1091-5] J Infect Dis 1996;173:1522-4.
8. Lafeuillade A, Poggi C, Tamalet C, Profizi N. Relationship between immune complex-dissociated p24 antigen and human immunodeficiency virus type 1 RNA titers in plasma [letter comment on J Infect Dis 1995;172:1091-5] J Infect Dis 1996;173:1522-4.
9. Lathey JL, Marschner IC, Kabat B, Spector SA. Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing. J Clin Microbiol 1997;35:631-5.
10. Lewis DE, Adu-Oppong A, Hollinger FB, Rosenblatt HM, Hanson IC, Reuben JM, et al. Sensitivity of immune complex-dissociated p24 antigen testing for early detection of human immunodeficiency virus in infants. Clin Diagn Lab Immunol 1995;2:87-90.
11. Paul MO, Toedter G, Hofheinz D, Tetali S, Pelton S, Marecki M, et al. Diagnosis of human immunodeficiency virus type 1 infection in infants by immune complex dissociation p24 assay. Clin Diagn Lab Immunol 1997;4:75-8.
12. Lyamuya E, Bredberg Raden U, Massawe A, Urassa E, Kawo G, Msemo G, et al. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12: 421-6.
13. Cabezas T, Quiros E, Garcia F, Hernandez Quero J, Bernal MC, Martinez MA, et al. Immune complex p24 antigen: A new prognostic marker in human immunodeficiency virus infection. Infection 1994;22:4-7.
14. Lillo FB, Cao Y, Concedi DR, Varnier OE. Improved detection of serum HIV p24 antigen after acid dissociation of immune complexes. AIDS 1993;7:1331-6.
15. Schupbach J, Flepp M, Pontelli D, Tomasik Z, Luthy R, Boni J. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplication render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS 1996;10:1085-90.
16. Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, et al. Time course and detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
17. Hashida S, Hashinaka K, Nishikata I, Saito A, Takamizawa A, Shinagawa H, et al. Earlier diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase in serum with enzyme immunoassay. J Clin Lab Anal 1996;10:213-19.
18. Kinloch S, Perrin L, Hirschel B. The risk of HIV transmission by screened blood. N Engl J Med 1996;334:992; discussion 993.
19. Nuchprayoon C, Tanprasert S, Chumnijarakij T. Is routine p24 HIV antigen screening justified in Thai blood donors? Lancet 1992;340:1041.
20. Stramer SL, Heller JS, Coombs RW, Parry JV, Ho DD, Allain J-P. Markers of HIV infection prior to IgG antibody seropositivity. JAMA 1989;262:64-9.
21. Campbell DG, Stephenson AJ, Li P, Oakeshott RD. Human immunodeficiency virus infection of human bone derived cells. Clin Orthop 1996;331:291-9.
22. Bigbee PD, Sarin PS, Humphreys JC, Eubanks WG, Sun D, Hocken DG, et al. Inactivation of human immunodeficiency virus (HIV) by ionizing radiation in body fluids and serological evidence. J Forensic Sci, JFSCA 1989;34:1303-10.
23. Campbell DG, Li P, Stephenson AJ, Oakeshott RD. Sterilization of HIV by gamma irradiation: A bone allograft model. Int Orthop 1994;18:172-6.